Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Francesca laganà"'
Autor:
Valeria Dipasquale, Ugo Cucinotta, Angela Alibrandi, Francesca Laganà, Vincenzo Ramistella, Claudio Romano
Publikováno v:
Nutrients, Vol 15, Iss 13, p 2875 (2023)
Tube feeding is a life-saving treatment for children with neurological disabilities (ND), who often suffer from malnutrition and feeding disorders. Nonetheless, it is still not widely used. Our aim was to evaluate the outcomes of exclusive tube feedi
Externí odkaz:
https://doaj.org/article/ec5f320b7a9a48b594ff05f0797e4640
Autor:
Valeria Dipasquale, Francesca Laganà, Serena Arrigo, Giuseppe Trimarchi, Carmelo Romeo, Giuseppe Navarra, Girolamo Mattioli, Paolo Gandullia, Claudio Romano
Publikováno v:
Biomedicines, Vol 10, Iss 9, p 2209 (2022)
This study reports the outcomes of an enhanced recovery after surgery (ERAS) protocol in pediatric inflammatory bowel disease (IBD) surgery. Children who underwent surgery for IBD at two academic referral centers from January 2016 to June 2021 were i
Externí odkaz:
https://doaj.org/article/8b81f2e6287245c8b584cdd140712179
Autor:
Letteria Morabito, Antonietta Spinuzza, Francesca Laganà, Giorgia Pepe, Tommaso Aversa, Malgorzata Wasniewska
Publikováno v:
Atti della Accademia Peloritana dei Pericolanti - Classe di Scienze Medico-Biologiche, Vol 107, Iss 1 (2019)
We describe a 13 years old girl with severe hypothyroidism due to Hashimoto’s Thyroiditis (HT) with an unusual clinical presentation, characterized only by growth arrest in absence of goiter and other clinical signs of overt hypothyroidism, like fa
Externí odkaz:
https://doaj.org/article/63d5476919e8492ea8480294c84229c2
Autor:
Valeria Dipasquale, Giuseppe Cicala, Francesca Laganà, Paola Cutroneo, Giuseppe Trimarchi, Edoardo Spina, Claudio Romano
Publikováno v:
Digestive and Liver Disease. 55:595-600
Proton pump inhibitors (PPIs) are widely prescribed in all age groups, and their use is increasing. However, their safety profile has been frequently questioned.The aim of this study was to analyze the characteristics of PPI-related adverse drug reac
Autor:
Ugo Cucinotta, Serena Arrigo, Valeria Dipasquale, Simone Maria Calogero Gramaglia, Francesca Laganà, Claudio Romano, Paolo Gandullia
Publikováno v:
Journal of Pediatric Gastroenterology & Nutrition. 76:590-595
Autor:
Romano, Valeria Dipasquale, Ugo Cucinotta, Angela Alibrandi, Francesca Laganà, Vincenzo Ramistella, Claudio
Publikováno v:
Nutrients; Volume 15; Issue 13; Pages: 2875
Tube feeding is a life-saving treatment for children with neurological disabilities (ND), who often suffer from malnutrition and feeding disorders. Nonetheless, it is still not widely used. Our aim was to evaluate the outcomes of exclusive tube feedi
Autor:
Patrizia Felicetti, Valeria Dipasquale, Claudio Romano, Giuseppe Cicala, Giuseppe Trimarchi, Edoardo Spina, Francesca Laganà, Paola Maria Cutroneo, Simona Potenza
Background The use of proton pump inhibitors (PPIs) has increased in the last ten years in children. Data regarding their safety profile are limited. The aim of this study was to analyze data from the Italian spontaneous reporting system (SRS) databa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb8d41265900bd25c79b4bba7abd7e2a
http://hdl.handle.net/11570/3211055
http://hdl.handle.net/11570/3211055
Publikováno v:
42th INTERNATIONAL CONFERENCE OF REPRESENTATION DISCIPLINES TEACHERS. CONGRESS OF UNIONE ITALIANA PER IL DISEGNO. PROCEEDINGS 2020. LINGUAGGI, DISTANZE, TECNOLOGIE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::75be0989c226717175ae753bc9baf7a4
https://doi.org/10.3280/oa-693.16
https://doi.org/10.3280/oa-693.16
Autor:
Sara Manti, Caterina Cuppari, Teresa Arrigo, Francesca Laganà, Rosangela Caruso, Valentina Giacchi, Vincenzo Salpietro, Salvatore Leonardi, Valeria Chirico, Carmelo Salpietro
Publikováno v:
Annals of allergy, asthmaimmunology : official publication of the American College of Allergy, Asthma,Immunology. 115(2)
The monitoring of asthma is based mainly on clinical history, physical examination, and lung function test evaluation. To improve knowledge of the disease, new biomarkers of airway inflammation, including high mobility group box-1 (HMGB1), are being